We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $12.4B
1-Year Est. Return 64.17%
This Fund
S&P 500
This Quarter Est. Return
+28.76%
1 Year Est. Return
+64.17%
3 Year Est. Return
+130.04%
5 Year Est. Return
+162.55%
10 Year Est. Return
+785.5%
AUM
$12.4B
AUM Growth
+$2.29B
Cap. Flow
-$8.07M
Cap. Flow %
-0.07%
Top 10 Hldgs %
9.07%
Holding
848
New
74
Increased
361
Reduced
233
Closed
101

Top Buys

Rank Stock Value
1
MANH icon
Manhattan Associates
MANH
+$43.3M
2
MSA icon
Mine Safety
MSA
+$37.1M
3
YSWY
Yesway Inc
YSWY
+$34.7M
4
DORM icon
Dorman Products
DORM
+$24.6M
5
AVTR icon
Avantor
AVTR
+$19M

Top Sells

Rank Stock Value
1
COHU icon
Cohu
COHU
+$54.5M
2
CPRX
Catalyst Pharmaceutical
CPRX
+$51.1M
3
MKSI icon
MKS Inc
MKSI
+$44.5M
4
VSH icon
Vishay Intertechnology
VSH
+$40.2M
5
LFUS icon
Littelfuse
LFUS
+$35.4M

Sector Composition

Rank Sector Weight
1 Industrials 27.04%
2 Technology 19.45%
3 Financials 14.84%
4 Consumer Discretionary 12.86%
5 Healthcare 9.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ODC icon
526
Oil-Dri
ODC
$1.33B
$4.14M 0.03%
40,532
-72,782
-64% -$5.82M
CIX icon
527
Comp X International
CIX
$394M
$4.14M 0.03%
166,074
– –
WSBC icon
528
WesBanco
WSBC
$3.88B
$4.13M 0.03%
105,847
+6,555
+7% +$231K
HLI icon
529
Houlihan Lokey
HLI
$9.3B
$4.09M 0.03%
30,495
-6,184
-17% -$912K
DHX icon
530
DHI Group
DHX
$176M
$4.08M 0.03%
1,098,945
+291,303
+36% +$962K
AGX icon
531
Argan
AGX
$5.86B
$3.99M 0.03%
4,994
-31,486
-86% -$20.9M
LNC icon
532
Lincoln National
LNC
$8.29B
$3.97M 0.03%
112,377
+65,807
+141% +$2.37M
BHRB icon
533
Burke & Herbert Financial Services Corp
BHRB
$1.45B
$3.95M 0.03%
54,973
-4,129
-7% -$267K
DGICA icon
534
Donegal Group Class A
DGICA
$714M
$3.95M 0.03%
209,183
+11,208
+6% +$195K
XENE icon
535
Xenon Pharmaceuticals
XENE
$5.81B
$3.93M 0.03%
+65,032
New +$3.61M
BPRN icon
536
Princeton Bancorp
BPRN
$288M
$3.81M 0.03%
100,389
+19,919
+25% +$713K
CMPS
537
Compass Pathways
CMPS
$1.9B
$3.78M 0.03%
267,059
-115,027
-30% -$1.17M
MCY icon
538
Mercury Insurance
MCY
$5.7B
$3.76M 0.03%
35,263
+12,983
+58% +$1.28M
HCC icon
539
Warrior Met Coal
HCC
$5.65B
$3.74M 0.03%
+46,072
New +$4.17M
LAB icon
540
Standard BioTools
LAB
$252M
$3.72M 0.03%
4,525,333
+1,519,804
+51% +$1.44M
MPB icon
541
Mid Penn Bancorp
MPB
$929M
$3.71M 0.03%
106,457
+6,148
+6% +$204K
GILD icon
542
Gilead Sciences
GILD
$181B
$3.66M 0.03%
29,000
– –
FFBC icon
543
First Financial Bancorp
FFBC
$3.45B
$3.66M 0.03%
108,149
+542
+0.5% +$16.6K
XERS icon
544
Xeris Biopharma Holdings
XERS
$1.55B
$3.65M 0.03%
461,153
+205,066
+80% +$1.31M
OII icon
545
Oceaneering
OII
$5.04B
$3.65M 0.03%
90,020
+7,003
+8% +$264K
GRDN
546
Guardian Pharmacy Services
GRDN
$2.35B
$3.65M 0.03%
87,096
– –
HAFC icon
547
Hanmi Financial
HAFC
$923M
$3.64M 0.03%
112,484
-679
-0.6% -$20.3K
SNA icon
548
Snap-on
SNA
$20.3B
$3.62M 0.03%
9,000
– –
ARES icon
549
Ares Management
ARES
$32.1B
$3.54M 0.03%
31,800
– –
RDN icon
550
Radian Group
RDN
$4.82B
$3.51M 0.03%
93,191
+1,417
+2% +$50.3K
20 21
22
23 24

Similar funds

JF
Jump Financial Chicago, Illinois $12.4B AUM 62.79% 1-Year Est. Return
WRCM
Whale Rock Capital Management Boston, Massachusetts $12.5B AUM 306.52% 1-Year Est. Return
Diamond Hill Capital Management
Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return
LC
Loews Corp New York $12.5B AUM 4.69% 1-Year Est. Return
AIM
Adapt Investment Managers Geneva, Switzerland $12.6B AUM 11.86% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
ERSOT
Employees Retirement System of Texas Austin, Texas $12.6B AUM 31.26% 1-Year Est. Return
BAMF
BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $12.6B AUM 41.69% 1-Year Est. Return

Royce & Associates's Q2 2026 Portfolio in Review

As of Q2 2026, Royce & Associates held 848 positions worth $12.4B, up 23% from $10.1B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.

Royce & Associates's Q2 2026 filing shows 74 new, 361 increased, 233 reduced and 101 closed positions. Its largest new stake was Manhattan Associates: 314,304 shares worth $43.8M. The largest sale was Cohu, an estimated $54.5M.

By sector, the portfolio is most concentrated in Industrials at 27% of assets, up from 26% a quarter earlier, followed by Technology and Financials.

  • Royce & Associates's largest Q2 2026 buy was Manhattan Associates: 314,304 shares worth $43.8M.
  • Royce & Associates added most to Mine Safety in Q2 2026, an estimated $37.1M increase.
  • Royce & Associates's biggest Q2 2026 reduction was Cohu, cutting an estimated $54.5M.
  • Royce & Associates fully exited Transmedics in Q2 2026, selling an estimated $24.3M.
  • Royce & Associates's ten largest holdings make up 9.1% of its $12.4B portfolio in Q2 2026.
  • Royce & Associates opened 74 new positions and closed 101 in Q2 2026.
  • Royce & Associates's portfolio value rose 23% quarter-over-quarter to $12.4B.

Based on Royce & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.